OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids
Renata Gorjão, César Miguel Momesso, Tamires Duarte Afonso Serdan, et al.
Pharmacology & Therapeutics (2018) Vol. 196, pp. 117-134
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications
Raquel D.S. Freitas, Maria M. Campos
Nutrients (2019) Vol. 11, Iss. 5, pp. 945-945
Open Access | Times Cited: 207

The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease
Chris McGlory, Philip C. Calder, Everson Araújo Nunes
Frontiers in Nutrition (2019) Vol. 6
Open Access | Times Cited: 160

Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition
Barbara Troesch, Manfred Eggersdorfer, Alessandro Laviano, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2555-2555
Open Access | Times Cited: 159

Futuristic food fortification with a balanced ratio of dietary ω-3/ω-6 omega fatty acids for the prevention of lifestyle diseases
Alok Patel, Sneha Sawant Desai, Varsha Kelkar Mane, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 140-153
Open Access | Times Cited: 92

Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach
Kunal C. Kadakia, Jill Hamilton‐Reeves, Vickie E. Baracos
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 35

FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer
Kumar S.D. Kothapalli, Hui Gyu Park, Niharika S.L. Kothapalli, et al.
Progress in Lipid Research (2023) Vol. 92, pp. 101242-101242
Open Access | Times Cited: 17

High levels of modified ceramides are a defining feature of murine and human cancer cachexia
Pauline Morigny, Julia Zuber, Mark Haid, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 6, pp. 1459-1475
Open Access | Times Cited: 43

The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia
Mit Joshi, Bhoomika M. Patel
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 6, pp. 1709-1723
Closed Access | Times Cited: 25

Targeting cancer cachexia: Molecular mechanisms and clinical study
Yongfei Wang, Zi‐Yi An, Donghai Lin, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 23

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
Giorgio Aquila, Andrea David Re Cecconi, Jeffrey J. Brault, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2536-2536
Open Access | Times Cited: 34

Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
Natalia E. Cortez, Gerardo G. Mackenzie
Nutrients (2021) Vol. 13, Iss. 9, pp. 3202-3202
Open Access | Times Cited: 27

Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
Jianfeng Yang, Kaiyi Ruan, Zhaowei Chu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Expression Levels of Long Non-Coding RNAs Change in Models of Altered Muscle Activity and Muscle Mass
Keisuke Hitachi, Masashi Nakatani, Shiori Funasaki, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1628-1628
Open Access | Times Cited: 28

Inflammation as a Therapeutic Target in Cancer Cachexia
Gerald H. Clamon, Margaret M. Byrne, Erin E. Talbert
Cancers (2022) Vol. 14, Iss. 21, pp. 5262-5262
Open Access | Times Cited: 16

The enzymatic synthesis of EPA-rich medium- and long-chain triacylglycerol improves the digestion behavior of MCFA and EPA: evidence onin vitrodigestion
Yandan Wang, Min‐Jie Cao, Ruijie Liu, et al.
Food & Function (2021) Vol. 13, Iss. 1, pp. 131-142
Closed Access | Times Cited: 21

Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies — exemplified by polyunsaturated fatty acids and other ROS-modulating agents
Ruixue Zhang, Franky Fuh-Ching Liu, HoYin Lip, et al.
Drug Delivery and Translational Research (2022) Vol. 12, Iss. 10, pp. 2303-2334
Closed Access | Times Cited: 14

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
Hiroteru Kamimura, Takeki Sato, Kazuki Natsui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1425-1425
Open Access | Times Cited: 18

Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting
Joshua R. Huot, Dryden R. Baumfalk, Aridai Resendiz, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 13

Dose-Dependent Impacts of Omega-3 Fatty Acids Supplementation on Anthropometric Variables in Patients With Cancer: Results From a Systematic Review and Meta-Analysis of Randomized Clinical Trials
Seyed Mojtaba Ghoreishy, Sheida Zeraattalab-Motlagh, Reza Amiri Khosroshahi, et al.
Clinical Nutrition Research (2024) Vol. 13, Iss. 3, pp. 186-186
Open Access | Times Cited: 2

N − 3 fatty acids during chemotherapy: toward a higher level of evidence for clinical application
Pamela Klassen, M. Cervantes, Vera C. Mazurak
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 23, Iss. 2, pp. 82-88
Closed Access | Times Cited: 16

Page 1 - Next Page

Scroll to top